These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 38707900)

  • 1. Potential therapeutic targets for membranous nephropathy: proteome-wide Mendelian randomization and colocalization analysis.
    Su Z; Wan Q
    Front Immunol; 2024; 15():1342912. PubMed ID: 38707900
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential drug targets for multiple sclerosis identified through Mendelian randomization analysis.
    Lin J; Zhou J; Xu Y
    Brain; 2023 Aug; 146(8):3364-3372. PubMed ID: 36864689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel therapeutic targets for primary open-angle glaucoma identified through multicenter proteome-wide mendelian randomization.
    Yuan W; Li J; Gao S; Sun W; Zhao F
    Front Pharmacol; 2024; 15():1428472. PubMed ID: 39221148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential drug targets for asthma identified in the plasma and brain through Mendelian randomization analysis.
    Wang Y; Wang J; Yan Z; Liu S; Xu W
    Front Immunol; 2023; 14():1240517. PubMed ID: 37809092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrative multi-omics summary-based mendelian randomization identifies key oxidative stress-related genes as therapeutic targets for atrial fibrillation and flutter.
    Chen S; Sun J; Wen W; Chen Z; Yu Z
    Front Genet; 2024; 15():1447872. PubMed ID: 39359474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic targets for muscle weakness in older adults: proteome-wide Mendelian randomization and colocalization analyses.
    Wang SK; Wang QJ; Zhao X; Wang P; Li XY; Wang W; Lu SB
    J Nutr Health Aging; 2024 Sep; 28(9):100325. PubMed ID: 39083861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ​Comprehensive mendelian randomization analysis of plasma proteomics to identify new therapeutic targets for the treatment of coronary heart disease and myocardial infarction.
    Sun Z; Yun Z; Lin J; Sun X; Wang Q; Duan J; Li C; Zhang X; Xu S; Wang Z; Xiong X; Yao K
    J Transl Med; 2024 Apr; 22(1):404. PubMed ID: 38689297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systematic proteome-wide Mendelian randomization using the human plasma proteome to identify therapeutic targets for lung adenocarcinoma.
    Zhang L; Xiong Y; Zhang J; Feng Y; Xu A
    J Transl Med; 2024 Apr; 22(1):330. PubMed ID: 38576019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploration of potential novel drug targets for diabetic retinopathy by plasma proteome screening.
    Yuan W; Xu W; Xu X; Qu B; Zhao F
    Sci Rep; 2024 May; 14(1):11726. PubMed ID: 38778174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel Drug Targets for Ischemic Stroke Identified Through Mendelian Randomization Analysis of the Blood Proteome.
    Chong M; Sjaarda J; Pigeyre M; Mohammadi-Shemirani P; Lali R; Shoamanesh A; Gerstein HC; Paré G
    Circulation; 2019 Sep; 140(10):819-830. PubMed ID: 31208196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of Novel Protein Biomarkers and Drug Targets for Acne Vulgaris by Integrating Human Plasma Proteome with Genome-Wide Association Data.
    Xu D; Yang X; Wu W; Yang J
    J Inflamm Res; 2024; 17():4431-4441. PubMed ID: 39006495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mendelian Randomization and Bayesian Colocalization Analysis Implicate Glycoprotein VI as a Potential Drug Target for Cardioembolic Stroke in South Asian Populations.
    Wu S; Meena D; Yarmolinsky J; Gill D; Smith A; Dib MJ; Chauhan G; Rohatgi A; Dehghan A; Tzoulaki I
    J Am Heart Assoc; 2024 Aug; 13(16):e035008. PubMed ID: 39119976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteome-wide Mendelian randomization identifies therapeutic targets for ankylosing spondylitis.
    Zhao W; Fang P; Lai C; Xu X; Wang Y; Liu H; Jiang H; Liu X; Liu J
    Front Immunol; 2024; 15():1366736. PubMed ID: 38566994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between circulating inflammatory markers and adult cancer risk: a Mendelian randomization analysis.
    Yarmolinsky J; Robinson JW; Mariosa D; Karhunen V; Huang J; Dimou N; Murphy N; Burrows K; Bouras E; Smith-Byrne K; Lewis SJ; Galesloot TE; Kiemeney LA; Vermeulen S; Martin P; Albanes D; Hou L; Newcomb PA; White E; Wolk A; Wu AH; Le Marchand L; Phipps AI; Buchanan DD; ; ; Zhao SS; Gill D; Chanock SJ; Purdue MP; Davey Smith G; Brennan P; Herzig KH; Järvelin MR; Amos CI; Hung RJ; Dehghan A; Johansson M; Gunter MJ; Tsilidis KK; Martin RM
    EBioMedicine; 2024 Feb; 100():104991. PubMed ID: 38301482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Causal association between cardiovascular proteins and membranous nephropathy: a bidirectional Mendelian randomization.
    Ma Q; Xu G
    Int Urol Nephrol; 2024 Aug; 56(8):2705-2714. PubMed ID: 38493415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteome-Wide Mendelian Randomization and Colocalization Analysis Identify Therapeutic Targets for Knee and Hip Osteoarthritis.
    Zou M; Shao Z
    Biomolecules; 2024 Mar; 14(3):. PubMed ID: 38540773
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multi-omics Mendelian randomization integrating GWAS, eQTL and pQTL data revealed GSTM4 as a potential drug target for migraine.
    Sun X; Chen B; Qi Y; Wei M; Chen W; Wu X; Wang Q; Li J; Lei X; Luo G
    J Headache Pain; 2024 Jul; 25(1):117. PubMed ID: 39039470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PTGES2 and RNASET2 identified as novel potential biomarkers and therapeutic targets for basal cell carcinoma: insights from proteome-wide mendelian randomization, colocalization, and MR-PheWAS analyses.
    Han QJ; Zhu YP; Sun J; Ding XY; Wang X; Zhang QZ
    Front Pharmacol; 2024; 15():1418560. PubMed ID: 39035989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Causal effect of gut microbiota on pancreatic cancer: A Mendelian randomization and colocalization study.
    Li X; Liang Z
    J Cell Mol Med; 2024 Apr; 28(8):e18255. PubMed ID: 38526030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL6 receptor inhibitors: exploring the therapeutic potential across multiple diseases through drug target Mendelian randomization.
    Fu C; Wang L; Cai W
    Front Immunol; 2024; 15():1452849. PubMed ID: 39229261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.